ArticlePulmonary medicine2014
Trends in pulmonary hypertension mortality and morbidity.
Article in Pulmonary medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 32 citations in OpenAlex.
- Factors Associated with Secondary Pulmonary Hypertension Among Hospitalized Females: An Artificial Neural Network Analysis of a National US Cohort.Journal of personalized medicine · 2026Article
- Prevalence and Economic Burden of Pulmonary Hypertension and Pulmonary Arterial Hypertension Among the Medicaid Population.Pulmonary circulation · 2025Article
- Impact of diabetes mellitus on mortality in pulmonary hypertension: A systematic review and meta-analysis.World journal of critical care medicine · 2024Article
- Mortality from pulmonary hypertension in Europe 2001-2019.BMC pulmonary medicine · 2024Article
- Pulmonary hypertension associated mortality in the United States from 2003 to 2020: an observational analysis of time trends and disparities.Journal of thoracic disease · 2023Article
- Risk Stratification in Pulmonary Arterial Hypertension, Update and Perspectives.Journal of clinical medicine · 2023Review
- Pulmonary hypertension mortality trends in United States 1999-2019.Annals of epidemiology · 2022Article
- Endobronchial Aerosolized AAV1.SERCA2a Gene Therapy in a Pulmonary Hypertension Pig Model: Addressing the Lung Delivery Bottleneck.Human gene therapy · 2022Article
- Article
- Sex and Gender Differences in Lung Disease.Advances in experimental medicine and biology · 2021Article
- Pulmonary arterial capacitance predicts outcomes in patients with pulmonary hypertension independent of race/ethnicity, sex, and etiology.Respiratory medicine · 2020Article
- Gender Differences in Risk Factors Associated With Pulmonary Artery Systolic Pressure, Heart Failure, and Mortality in Blacks: Jackson Heart Study.Journal of the American Heart Association · 2020Observational
- Observational
- Diabetes Mellitus Associates with Increased Right Ventricular Afterload and Remodeling in Pulmonary Arterial Hypertension.The American journal of medicine · 2018Article
- Article
- Trends and Outcomes of Pulmonary Arterial Hypertension-Related Hospitalizations in the United States: Analysis of the Nationwide Inpatient Sample Database From 2001 Through 2012.JAMA cardiology · 2016Article
- Prognostic Factors in Patients With Pulmonary Hypertension-A Nationwide Cohort Study.Journal of the American Heart Association · 2016Observational
- TRPC6 is required for hypoxia-induced basal intracellular calcium concentration elevation, and for the proliferation and migration of rat distal pulmonary venous smooth muscle cells.Molecular medicine reports · 2016Article
- BMPR2 spruces up the endothelium in pulmonary hypertension.Protein & cell · 2015Review
- To be EndMT or not to be, that is the question in pulmonary hypertension.Protein & cell · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
contextFew reports have been published regarding surveillance data for pulmonary hypertension, a debilitating and often fatal condition.
aimsWe report trends in pulmonary hypertension. SETTINGS AND
designUnited States of America; vital statistics, hospital data. METHODS AND MATERIAL: We used mortality data from the National Vital Statistics System (NVSS) for 1999-2008 and hospital discharge data from the National Hospital Discharge Survey (NHDS) for 1999-2009. STATISTICAL ANALYSIS USED: We present age-standardized rates. Results. Since 1999, the numbers of deaths and hospitalizations as well as death rates and hospitalization rates for pulmonary hypertension have increased. In 1999 death rates were higher for men than for women; however, by 2002, no differences by gender remained because of the increasing death rates among women and the declining death rates among men; after 2003 death rates for women were higher than for men. Death rates throughout the reporting period 1999-2008 were higher for blacks than for whites. Hospitalization rates in women were 1.3-1.6 times higher than in men.
conclusionsPulmonary hypertension mortality and hospitalization numbers and rates increased from 1999 to 2008.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.